Results 71 to 80 of about 1,616 (165)

Keratosis pilaris atrophicans faciei: An observational, descriptive, retrospective clinical study. [PDF]

open access: yesExp Ther Med, 2021
Fekete GL   +5 more
europepmc   +1 more source

Skin manifestations in diabetes—what is new?

open access: yesFrontiers in Medicine
Diabetes is a chronic disease with a continuously increasing prevalence worldwide. Chronic hyperglycaemia results from elevated blood glucose levels due to disturbed insulin secretion and/or action.
Natalia Dorf, Mateusz Maciejczyk
doaj   +1 more source

Pityriasis Rubra Pilaris In The Indian Scenario

open access: yesIndian Journal of Dermatology, 2002
Pityriasis rubra pilaris (PRP) is an uncommon idiopathic papulosqamous disorder characterized by circumscribed follicular keratosis, palmoplantar keratoderma and frequently erythroderma. Seven patients of PRP (five females and two males) in the age range
Sarkar Rashmi   +3 more
doaj  

Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial. [PDF]

open access: yesDermatol Ther (Heidelb), 2022
Li M   +8 more
europepmc   +1 more source

Atopic Dermatitis - A Clinical Profile

open access: yesIndian Journal of Dermatology, 1998
A total of 80 atopic dermatitis cases were studied. The incidence was 4.2 per 1000 among OPD patients. The overall crude M : F ratio was 1.4:1 which after standardization was 0.9:1, 32.5% had the disease for the first time, 48.75% of ...
Kumar Pramod, Pai Ganesh S
doaj  

Clinical outcomes and 5-year follow-up results of keratosis pilaris treated by a high concentration of glycolic acid. [PDF]

open access: yesWorld J Clin Cases, 2021
Tian Y   +10 more
europepmc   +1 more source

Dermoscopy of Anserine Folliculosis

open access: yesDermatology Practical & Conceptual, 2021
Shekhar Neema, Shivam Goyal
doaj   +1 more source

Presentations of Cutaneous Disease in Various Skin Pigmentations: Keratosis Pilaris. [PDF]

open access: yesHCA Healthc J Med
Lim H   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy